Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease

Author(s):  Glasnapp Andrew, Schaefer Erin

Issue:  Jul/Aug 2000 - Compounding for Hospice and Cancer Patients
View All Articles in Issue

Page(s):  276-279

Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease Page 1
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease Page 2
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease Page 3
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease Page 4

Download in electronic PDF format for $65

Abstract:  Nicotinamide-adenine dinucleotide (NADH) is currently being tested as a promising new therapy in the treatment of Parkinson’s and Alzheimer’s disease. The authors discuss some of these studies, in addition to providing figures showing the synthesis of dopamine and the Kreb’s cycle and providing tables showing results of the Birkmayer Parkinison’s Disease Study and the Mini-Mental State Examination. They also provide a formulation for NADH Capsules.

Related Keywords: adenine, alzheimer's, coenzyme I, dinucleotide, dopamine, levodopa, mini-mental state exam, motor function, NADH, neurochemistry, neurology, Nicotinamide, parkinson's, tetrahydrobiopterin, tyrosine

Related Categories: GERIATRICS, MENTAL HEALTH

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Glasnapp Andrew
, Schaefer Erin
Jul/Aug 2000
Pg. 276-279

Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient
Bramwell Bethany
Jul/Aug 2011
Pg. 316-319

Levodopa and Carbidopa Rectal Suspension
Allen Loyd V Jr
Mar/Apr 2018
Pg. 149

Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease
Osburn Jennifer
May/Jun 2002
Pg. 171-176

Dopamine Hydrochloride 80-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 505

In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers
Bhattacharya Sisir
, Parekh Satish, Dedhiya Mahendra
Sep/Oct 2015
Pg. 432-436

Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2021
Pg. 145

Carnitine 400-mg/mL and Coenzyme Q10 10-mg/mL Solution
Allen Loyd V Jr
Sep/Oct 2008
Pg. 448

Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Bramwell Bethany L
Mar/Apr 2010
Pg. 108-111

Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
Mar/Apr 2021
Pg. 115-124